Individual susceptibility to cadmium toxicity and metallothionein gene polymorphisms: With references to current status of occupational cadmium exposure

Industrial Health

Volumn 47, Issue 5, 2009, Pages 487-494

  Miura, Nobuhiko ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

Author keywords

Cadmium; Metallothionein; Occupational exposure; Polymorphism

Indexed keywords

CADMIUM; METALLOTHIONEIN;

BONE INJURY; CADMIUM POISONING; CARCINOGENESIS; CARDIOVASCULAR DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DRUG ACCUMULATION; FOOD CONTAMINATION; HUMAN; HYPERTENSION; INDUSTRIAL WORKER; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY TUBULE DISORDER; LONG TERM EXPOSURE; MALE INFERTILITY; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; WORK ENVIRONMENT;

BIOLOGICAL MARKERS; CADMIUM POISONING; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; KIDNEY CORTEX; METALLOTHIONEIN; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC;

EID: 70350329177     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.47.487     Document Type: Review

References (89)

1. Friis L, Petersson L, Edling C (1998) Reduced cadmium levels in human kidney cortex in Sweden. Environ Health Perspect 106, 175-178 (Pubitemid 28206266)
2. Miyamoto T, Kobayashi E, Suwazono Y, Uetani M, Nishijo M, Miura K, Nakagawa H, Nogawa K (2006) Changes in urinary excretions of cadmium, copper, and zinc in Japanese workers. Arch Environ Occup Health 61, 215-222 (Pubitemid 47425160)
3. Uno T, Kobayashi E, Suwazono Y, Okubo Y, Miura K, Sakata K, Okayama A, Ueshima H, Nakagawa H, Nogawa K (2005) Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium. Scand J Work Environ Health 31, 307-315 (Pubitemid 41226938)
4. Yassin AS, Martonik JF (2004) Urinary cadmium levels in the US working population, 1988-1994. J Occup Environ Hyg 1, 324-333
5. Sethi PK, Khandelwal D (2006) Cadmium exposure: health hazards of silver cottage industry in developing countries. J Med Toxicol 2, 14-15
6. Orisakwe OE, Nwachukwu E, Osadolor HB, Afonne OJ, Okocha CE (2007) Liver and kidney function tests amongst paint factory workers in Nkpor, Nigeria. Toxicol Ind Health 23, 161-165 (Pubitemid 350178895)
7. Vitayavirasuk B, Junhom S, Tantisaeranee P (2005) Exposure to lead, cadmium and chromium among spray painters in automobile body repair shops. J Occup Health 47, 518-522 (Pubitemid 43203786)
8. Jin T, Kong Q, Ye T, Wu X, Nordberg GF (2004) Renal dysfunction of cadmium-exposed workers residing in a cadmium-polluted environment. Biometals 17, 513-518 (Pubitemid 41214259)
9. Sorahan T, Esmen NA (2004) Lung cancer mortality in UK nickel-cadmium battery workers, 1947-2000. Occup Environ Med 61, 108-116 (Pubitemid 38141967)
10. Centers for Disease Control and Prevention (2002) Occupational exposures to air contaminants at the World Trade Center disaster site - New York, September-October, 2001. MMWR Morb Mortal Wkly Rep 51, 453-456
11. Wallingford KM, Snyder EM (2001) Occupational exposures during the World Trade Center disaster response. Toxicol Ind Health 17, 247-253 (Pubitemid 36098370)
12. Perez-Cadahia B, Laffon B, Porta M, Lafuente A, Cabaleiro T, Lopez T, Caride A, Pumarega J, Romero A, Pasaro E, Mendez J (2008) Relationship between blood concentrations of heavy metals and cytogenetic and endocrine parameters among subjects involved in cleaning coastal areas affected by the 'Prestige' tanker oil spill. Chemosphere 71, 447-455
13. Panchal L, Vaideeswar P (2006) Acute lung injury due to cadmium inhalation - a case report. Indian J Pathol Microbiol 49, 265-266 (Pubitemid 44276707)
14. Barbee JY Jr, Prince TS (1999) Acute respiratory distress syndrome in a welder exposed to metal fumes. South Med J 92, 510-512
15. Morris TK (2004) Cadmium exposures at three nonferrous foundries: an unexpected trace source. J Occup Environ Hyg 1, 39-44.
16. Sişman AR, Bübül M, Coker C, Onvural B (2003) Cadmium exposure in tobacco workers: possible renal effects. J Trace Elem Med Biol 17, 51-55 (Pubitemid 36538172)
17. D'Elia V, Lodi V, Naldi M, Gherardi G, Violante FS, Bonparola M, Badiello R, Raffi GB (1999) Gardening work and heavy metals in urban environment. Arh Hig Rada Toksikol 50, 163-170
18. Japan Mining Industry Association (2005) Bulletin of Japan Mining Industry Association 58, 53-127 (in Japanese).
19. Yamagata N, Shigematsu I (1970) Cadmium pollution in perspective. Bull Inst Publilc Health 19, 18-24.
20. Uetani M, Kobayashi E, Suwazono Y, Honda R, Nishijo M, Nakagawa H, Kido T, Nogawa K (2006) Tissue cadmium (Cd) concentrations of people living in a Cd polluted area, Japan. Biometals 19, 521-525
21. Muramoto S, Nishizaki H, Aoyama I (1990) The critical levels and the maximum metal uptake for wheat and rice plants when applying metal oxides to soil. J Environ Sci Health B 25, 273-280
22. Watanabe Y, Kobayashi E, Okubo Y, Suwazono Y, Kido T, Nogawa K (2002) Relationship between cadmium concentration in rice and renal dysfunction in individual subjects of the Jinzu River basin determined using a logistic regression analysis. Toxicology 172, 93-101. (Pubitemid 34214781)
23. Ohta H, Cherian MG (1991) Gastrointestinal absorption of cadmium and metallothionein. Toxicol Appl Pharmacol 107, 63-72.
24. Ohta H, Yamauchi Y, Nakakita M, Tanaka H, Asami S, Seki Y, Yoshikawa H (2000) Relationship between renal dysfunction and bone metabolism disorder in male rats after long-term oral quantitative cadmium administration. Ind Health 38, 339-355 (Pubitemid 30836115)
25. Kägi JH (1991) Overview of metallothionein. Methods Enzymol 205, 613-626
26. Webb M (1979) Metallothionein. In: The chemistry, biochemistry and biology of cadmium. Webb M (Ed.), 195-266, Elsevier, Amsterdam.
27. Klaassen CD, Liu J, Choudhuri S (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39, 267-294 (Pubitemid 29222560)
28. Nordberg GF, Goyer R, Nordberg M (1975) Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney. Arch Pathol 99, 192-197
29. WHO (1992) Environmental Health Criteria 134 Cadmium. World Health Organization, Geneva.
30. Yoshida M, Ohta H, Yamauchi Y, Seki Y, Sagi M, Yamazaki K, Sumi Y (1998) Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol Trace Elem Res 63, 167-175 (Pubitemid 28523194)
31. Kjellstrom T, Evrin PE, Rahnster B (1977) Dose-response analysis of cadmium-induced tubular protein-uria: a study of urinary beta2-microglobulin excretion among workers in a battery factory. Environ Res 13, 303-317 (Pubitemid 8093880)
32. Nogawa K, Kido T, Yamada Y, Tsuritani I, Honda R, Ishizaki M, Terahata K (1984) Alpha 1-microglobulin in urine as an indicator of renal tubular damage caused by environmental cadmium exposure. Toxicol Lett 22, 63-68
33. Goyer RA, Epstein S, Bhattacharyya M, Korach KS, Pounds J (1994) Environmental risk factors for osteoporosis. Environ Health Perspect 102, 390-394 (Pubitemid 24164502)
34. Zhu G, Wang H, Shi Y, Weng S, Jin T, Kong Q, Nordberg GF (2004) Environmental cadmium exposure and forearm bone density. Biometals 17, 499-503. (Pubitemid 41214256)
35. Horiguchi H, Sato M, Konno N, Fukushima M (1996) Long-term cadmium exposure induces anemia in rats through hypoinduction of erythropoietin in the kidneys. Arch Toxicol 71, 11-19 (Pubitemid 26402864)
36. Horiguchi H, Teranishi H, Niiya K, Aoshima K, Katoh T, Sakuragawa N, Kasuya M (1994) Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan. Arch Toxicol 68, 632-636 (Pubitemid 24316703)
37. Akiba T, Endou H, Koseki C, Sakai F, Horiuchi N, Suda T (1980) Localization of 25-hydroxyvitamin D3-1 alpha-hydroxylase activity in the mammalian kidney. Biochem Biophys Res Commun 94, 313-318
38. Nogawa K, Tsuritani I, Kido T, Honda R, Yamada Y, Ishizaki M (1987) Mechanism for bone disease found in inhabitants environmentally exposed to cadmium: decreased serum 1 alpha, 25-dihydroxyvitamin D level. Int Arch Occup Environ Health 59, 21-30.
39. Lopez MG, Moro MA, Castillo CF, Artalejo CR, Garcia AG (1989) Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion. Br J Pharmacol 96, 725-731
40. Gobba F (2006) Olfactory toxicity: long-term effects of occupational exposures. Int Arch Occup Environ Health 79, 322-331
41. Queiroz EK, Waissmann W (2006) Occupational exposure and effects on the male reproductive system. Cad Saude Publica 22, 485-493
42. Glauser SC, Bello CT, Glauser EM (1976) Blood-cadmium levels in normotensive and untreated hypertensive humans. Lancet 1, 717-718
43. Houtman JP (1993) Prolonged low-level cadmium intake and atherosclerosis. Sci Total Environ 138, 31-36 (Pubitemid 23359811)
44. Wild P, Bourgkard E, Paris C (2009) Lung cancer and exposure to metals: the epidemiological evidence. Methods Mol Biol 472, 139-167
45. Il'yasova D, Schwartz GG (2005) Cadmium and renal cancer. Toxicol Appl Pharmacol 207, 179-186
46. Sahmoun AE, Case LD, Jackson SA, Schwartz GG (2005) Cadmium and prostate cancer: a critical epidemiologic analysis. Cancer Invest 23, 256-263
47. Coyle YM (2004) The effect of environment on breast cancer risk. Breast Cancer Res Treat 84, 273-288 (Pubitemid 38445377)
48. Wesseling C, Pukkala E, Neuvonen K, Kauppinen T, Boffetta P, Partanen T (2002) Cancer of the brain and nervous system and occupational exposures in Finnish women. J Occup Environ Med 44, 663-668 (Pubitemid 34764981)
49. Verougstraete V, Lison D, Hotz P (2003) Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. J Toxicol Environ Health B Crit Rev 6, 227-255 (Pubitemid 36520934)
50. Verougstraete V, Lison D, Hotz P (2002) A systematic review of cytogenetic studies conducted in human populations exposed to cadmium compounds. Mutat Res 511, 15-43.
51. Nawrot T, Plusquin M, Hogervorst J, Roels HA, Celis H, Thijs L, Vangronsveld J, Van Hecke E, Staessen JA (2006) Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 7, 119-126 (Pubitemid 43159497)
52. Arisawa K, Uemura H, Hiyoshi M, Dakeshita S, Kitayama A, Saito H, Soda M (2007) Cause-specific mortality and cancer incidence rates in relation to urinary beta2-microglobulin: 23-year follow-up study in a cadmium-polluted area. Toxicol Lett 173, 168-174 (Pubitemid 47391549)
53. Arisawa K, Nakano A, Saito H, Liu XJ, Yokoo M, Soda M, Koba T, Takahashi T, Kinoshita K (2001) Mortality and cancer incidence among a population previously exposed to environmental cadmium. Int Arch Occup Environ Health 74, 255-262 (Pubitemid 32454559)
54. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB (2003) Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9, 1081-1084 (Pubitemid 37021790)
55. Satarug S, Moore MR (2004) Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112, 1099-1103 (Pubitemid 39029166)
56. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA (2006) Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98, 869-873 (Pubitemid 43923443)
57. Stoica A, Katzenellenbogen BS, Martin MB (2000) Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14, 545-553 (Pubitemid 32260523)
58. Choe SY, Kim SJ, Kim HG, Lee JH, Choi Y, Lee H, Kim Y (2003) Evaluation of estrogenicity of major heavy metals. Sci Total Environ 312, 15-21. (Pubitemid 36836198)
59. Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G, Mariani S, Cherubini S, d'Abusco AS, Scandurra R, Migliaccio S (2007) Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol Cell Endocrinol 264, 102-108 (Pubitemid 46110939)
60. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, Dagata RS, Bull JL, Stoica A (2003) Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144, 2425-2436 (Pubitemid 36629894)
61. Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu H (2005) Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 14, 705-708 (Pubitemid 40489218)
62. Alonso-Gonzalez C, Gonzalez A, Mazarrasa O, Guezmes A, Sanchez-Mateos S, Martinez-Campa C, Cos S, Sanchez-Barcelo EJ, Mediavilla MD (2007) Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus. J Pineal Res 42, 403-410 (Pubitemid 46581665)
63. Martinez-Campa C, Alonso-Gonzalez C, Mediavilla MD, Cos S, Gonzalez A, Ramos S, Sanchez-Barcelo EJ (2006) Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 40, 291-296
64. O'Brien P, Salacinski HJ (1998) Evidence that the reactions of cadmium in the presence of metallothionein can produce hydroxyl radicals. Arch Toxicol 72, 690-700. (Pubitemid 29001918)
65. Ozan E, Sonmez MF, Ozan S, Colakoglu N, Yilmaz S, Kuloglu T (2007) Effects of melatonin and vitamin C on cigarette smoke-induced damage in the kidney. Toxicol Ind Health 23, 479-485
66. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL (1993) Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol 13, 5266-5275 (Pubitemid 23260631)
67. Liu Y, Liu J, Habeebu SM, Waalkes MP, Klaassen CD (2000) Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. Toxicol Sci 57, 167-176 (Pubitemid 30683279)
68. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 91, 584-588
69. Michalska AE, Choo KH (1993) Targeting and germline transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA 90, 8088-8092 (Pubitemid 23260860)
70. Kjellstrom T (1979) Exposure and accumulation of cadmium in populations from Japan, the United States, and Sweden. Environ Health Perspect 28, 169-197
71. Takebayashi S, Jimi S, Segawa M, Kiyoshi Y (2000) Cadmium induces osteomalacia mediated by proximal tubular atrophy and disturbances of phosphate reabsorption. A study of 11 autopsies. Pathol Res Pract 196, 653-663 (Pubitemid 30690140)
72. Kita K, Miura N, Yoshida M, Yamazaki K, Ohkubo T, Imai Y, Naganuma A (2006) Potential effect on cellular response to cadmium of a single-nucleotide A → G polymorphism in the promoter of the human gene for metallothionein IIA. Hum Genet 120, 553-560 (Pubitemid 44669788)
73. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T (1990) Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5, 1037-1043 (Pubitemid 20220246)
74. JECFA (2004) Evaluation of certain food additives and contaminants. Sixty-first Report of the Joint FAO/WHO Expert Committee on Food Additives, 127-132.
75. Yamada H, Koizumi S (2001) Lymphocyte metallothionein-mRNA as a sensitive biomarker of cadmium exposure. Ind Health 39, 29-32. (Pubitemid 32157903)
76. Ganguly S, Taioli E, Baranski B, Cohen B, Toniolo P, Garte SJ (1996) Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. Cancer Epidemiol Biomarkers Prev 5, 297-301. (Pubitemid 26116019)
77. Liu J, Cheng ML, Yang Q, Shan KR, Shen J, Zhou Y, Zhang X, Dill AL, Waalkes MP (2007) Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China. Environ Health Perspect 115, 1101-1106 (Pubitemid 47317078)
78. Chang X, Jin T, Chen L, Nordberg M, Lei L (2009) Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational Cadmium exposure. Exp Biol Med 234, 666-672
79. JECFA (1972) Evaluation of certain food additives and contaminants mercury, lead and cadmium. Sixteenth Report of the Joint FAO/WHO Expert Committee on Food Additives, 20-24
80. Satoh M, Kloth DM, Kadhim SA, Chin JL, Naganuma A, Imura N, Cherian MG (1993) Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 53, 1829-1832 (Pubitemid 23127110)
81. Stein AF, Bracken WM, Klaassen CD (1987) Utilization of methionine as a sulfhydryl source for metallothionein synthesis in rat primary hepatocyte cultures. Toxicol Appl Pharmacol 87, 276-283
82. Shibuya K, Cherian MG, Satoh M (1997) Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor. Radiat Res 148, 235-239 (Pubitemid 27374100)
83. Valberg LS, Sorbie J, Hamilton DL (1976) Gastrointestinal metabolism of cadmium in experimental iron deficiency. Am J Physiol 231, 462-467
84. Flanagan PR, McLellan JS, Haist J, Cherian G, Chamberlain MJ, Valberg LS (1978) Increased dietary cadmium absorption in mice and human subjects with iron deficiency. Gastroenterology 74, 841-846 (Pubitemid 8332337)
85. Olsson IM, Bensryd I, Lundh T, Ottosson H, Skerfving S, Oskarsson A (2002) Cadmium in blood and urine - impact of sex, age, dietary intake, iron status, and former smoking - association of renal effects. Environ Health Perspect 110, 1185-1190 (Pubitemid 36024301)
86. Olsson IM, Eriksson J, Oborn I, Skerfving S, Oskarsson A (2005) Cadmium in food production systems: a health risk for sensitive population groups. Ambio 34, 344-351 (Pubitemid 40995870)
87. Oskarsson A, Widell A, Olsson IM, Grawe KP (2004) Cadmium in food chain and health effects in sensitive population groups. Biometals 17, 531-534 (Pubitemid 41214262)
88. Andersen O, Nielsen JB, Nordberg GF (2004) Nutritional interactions in intestinal cadmium uptake - possibilities for risk reduction. Biometals 17, 543-547 (Pubitemid 41214265)
89. Horiguchi H, Oguma E, Sasaki S, Miyamoto K, Ikeda Y, Machida M, Kayama F (2004) Comprehensive study of the effects of age, iron deficiency, diabetes mellitus, and cadmium burden on dietary cadmium absorption in cadmium-exposed female Japanese farmers. Toxicol Appl Pharmacol 196, 114-123 (Pubitemid 38393699)